Walter P Maksymowych

University of Alberta

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

SFE van Weely

Leiden University Medical Center

NETHERLANDS

View details

Sofia Ramiro

Leiden University Medical Center

NETHERLANDS

View details

Carter Thorne

Consultant & Chief

Rockbridge Area Health Center

CANADA

View details

Denis Poddubnyy

GERMANY

View details

Alexander Pfeil

GERMANY

View details

Mikkel Østergaard

Professor

Rigshospitalet

DENMARK

View details

Robert Landewé

Professor

Amsterdam University Medical Centers

NETHERLANDS

View details

Désirée van der Heijde

Professor

Leiden University Medical Center

NETHERLANDS

View details

Margaret J Larché

McMaster University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Walter P Maksymowych

Research Interests

Explore related searches

Contact this professor

Articles (11)

Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition

Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis

Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis

Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: Results from the TORTUGA trial

Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial)

Improving the design of RCTs in non-radiographic axial spondyloarthritis

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: Results from open-label extension

Collaborators (9)

SFE van Weely

Sofia Ramiro

Carter Thorne

Denis Poddubnyy

Alexander Pfeil

Mikkel Østergaard

Robert Landewé

Désirée van der Heijde

Margaret J Larché

Make your next move.